The pharma industry is moving away from traditional in-house innovation and toward a more diversified business model, but will encounter …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

